In the BioHarmony Drug Report Database

"Preview" Icon

Ciprofloxacin

Cipro, Otiprio (ciprofloxacin) is a small molecule pharmaceutical. Ciprofloxacin was first approved as Cipro on 1990-12-26. It is used to treat anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, and bacteroides infections amongst others in the USA. Ciprodex’s patents are valid until 2037-11-12 (FDA).

 

Trade Name

 

Cipro, Otiprio
 

Common Name

 

ciprofloxacin
 

ChEMBL ID

 

CHEMBL8
 

Indication

 

anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, bacteroides infections, campylobacter infections, cystitis, diarrhea, dysentery, escherichia coli infections, fever, gonorrhea, haemophilus infections, infectious arthritis, intraabdominal infections, klebsiella infections, neutropenia, osteomyelitis, otitis externa, prostatitis, proteus infections, protozoan infections, pseudomonas infections, pyelonephritis, sinusitis, staphylococcal infections, typhoid fever, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Ciprofloxacin structure rendering